MICHELLE DYESS: Open Payments
NPI 1609276161 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 24 payments from 9 companies in 2025. Trend: 2023 $414 · 2024 $880 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| IBSA Pharma Inc. | 6 | $113 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $112 |
| Ipsen Biopharmaceuticals, Inc | 3 | $88 |
| Boston Scientific Corporation | 1 | $83 |
| ABBVIE INC. | 3 | $57 |
| Merz Pharmaceuticals, LLC | 2 | $52 |
| Dynasplint Systems Inc. | 1 | $40 |
| Globus Medical, Inc. | 1 | $30 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
Products named: Tirosint, RELISTOR, Dysport, Intracept RF Probe, BOTOX, Xeomin, Dynasplint, Senza.
Industry payments across LA — which companies pay providers there.
